September 21, 2023

Breast Cancer Recurrence May Be Triggered By Chemotherapy Injury To Non-Cancer Cells

A standard chemotherapy drug injures surrounding non-cancer cells, which can then awaken dormant cancer cells and promote cancer growth, according to a new study published in the open access journal PLoS Biology.
September 21, 2023

Study Identifies Adverse Association Between Calcium Channel Blocking Drugs And Glaucoma

There is an adverse association between calcium channel blocker use and glaucoma, according to a study published online in JAMA Ophthalmology.
September 14, 2023

Painkillers Combined With Contraceptive Pill Could Increase Risk of Blood Clots Among Women

Women are being warned that taking some common painkillers while using the contraceptive pill may increase their risk of suffering blood clots.
August 31, 2023

Bayer Investor Calls For Company To Be Broken Up

Bayer needs to make major changes, including "de-merging" two of its three business arms, investor Artisan Partners has told Reuters, adding to a chorus of demand for change from other investors.
August 25, 2023

Pfizer Loses $144 Billion in Value

Pfizer has lost $88 billion in market share and $144 billion in value since its market peak in just one year.
August 18, 2023

New Osteoporosis Drug May Increase Heart Attack Risk, Genetic Study Reveals

Concerning new research is highlighting potential health hazards for women who take romosozumab, a new anti-osteoporosis drug. Researchers from the University of Bristol say using the medication to treat the bone disease could lead to a heart attack.
August 18, 2023

Long-Term Use of Certain Reflux Medications Associated With Higher Risk of Dementia

Millions of Americans take medications known as proton pump inhibitors every day to treat heartburn and acid reflux. In recent years, these drugs have been linked to a greater risk of kidney failure, stroke, and early death. New research suggests there may also be a higher risk of dementia.
August 18, 2023

US Supreme Court Halts Purdue Pharma Deal That Shields Sackler Family From Lawsuits

The US supreme court has agreed to hear a challenge to the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement that would shield its owners, the Sackler family, from lawsuits over their role in America’s opioid epidemic.